Cargando…

Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants

Green tea is a popular beverage worldwide. The abundant green tea catechin (−)‐epigallocatechin gallate (EGCG) is a potent in vitro inhibitor of intestinal UDP‐glucuronosyltransferase (UGT) activity (K ( i ) ~2 μM). Co‐consuming green tea with intestinal UGT drug substrates, including raloxifene, co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, John D., Judson, Sabrina M., Tian, Dan‐Dan, Kirby, Trevor O., Tanna, Rakshit S., Matula‐Péntek, Adrienn, Horváth, Miklós, Layton, Matthew E., White, John R., Cech, Nadja B., Thummel, Kenneth E., McCune, Jeannine S., Shen, Danny D., Paine, Mary F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582660/ https://www.ncbi.nlm.nih.gov/pubmed/37639334 http://dx.doi.org/10.1111/cts.13578

Ejemplares similares

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

Oxidative Stress and Raloxifene
por: Akgol, Gurkan, et al.
Publicado: (2012)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Hemostatic Effects of Raloxifene in Ovariectomized Rats
por: Alva-Chavarría, Denys, et al.
Publicado: (2023)

Raloxifene for older women: a review of the literature
por: Hansdóttir, Helga
Publicado: (2008)

Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride
por: Reddy, Reguri Buchi, et al.
Publicado: (2012)

Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients
por: Iwamoto, Jun
Publicado: (2012)

Significant Effect of Raloxifene on Bone in Hemodialysis Patients
por: Ravn, Pernille
Publicado: (2012)

Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
por: Reimão, Juliana Q., et al.
Publicado: (2014)

The Pharmacokinetics of Raloxifene and Its Interaction with Apigenin in Rat
por: Chen, Yan, et al.
Publicado: (2010)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Raloxifene as a treatment option for viral infections
por: Hong, Subin, et al.
Publicado: (2021)

Raloxifene induced keratopathy: A case report
por: Park, Ji Min, et al.
Publicado: (2022)

Comparison of Metabolomics Approaches for Evaluating the Variability of Complex Botanical Preparations: Green Tea (Camellia sinensis) as a Case Study
por: Kellogg, Joshua J., et al.
Publicado: (2017)

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007)

Raloxifene inhibits hepatitis C virus infection and replication
por: Takeda, Midori, et al.
Publicado: (2012)

Effects of Raloxifene on Bone in Patients With Type 2 Diabetes
por: Gorai, Itsuo
Publicado: (2012)

Raloxifene May Have Further Benefits in Women on Hemodialysis
por: Worsley, Roisin, et al.
Publicado: (2012)

Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
por: Murthy, Aditya, et al.
Publicado: (2020)

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
por: Foster, Shonda A, et al.
Publicado: (2013)

Translating Kratom-Drug Interactions: From Bedside to Bench and Back
por: Tanna, Rakshit S., et al.
Publicado: (2023)

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates
por: Foster, Shonda A, et al.
Publicado: (2008)

Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal
por: Elsheikh, Manal A, et al.
Publicado: (2012)

Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Alendronate and Raloxifene Therapy in the Early Period after Hip Fracture
por: Ohishi, Tsuyoshi, et al.
Publicado: (2011)

Solubility Enhancement of Raloxifene Using Inclusion Complexes and Cogrinding Method
por: Patil, Payal H., et al.
Publicado: (2013)

Effect of aerobic exercise and raloxifene combination therapy on senile osteoporosis
por: Zhao, Chengjin, et al.
Publicado: (2016)

Anti-Estrogen Withdrawal Effect With Raloxifene? A Case Report
por: Lemmo, Walter
Publicado: (2016)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Raloxifene is a Female-specific Proteostasis Therapeutic in the Spinal Cord
por: Jenkins, Edmund Charles, et al.
Publicado: (2020)

First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
por: Norimatsu, Yurie, et al.
Publicado: (2021)

Raloxifene Ameliorates Glucosamine-Induced Insulin Resistance in Ovariectomized Rats
por: Chen, Chung-Hwan, et al.
Publicado: (2021)

Elasomeran/raloxifene: Acute venous thromboembolism: 3 case reports
Publicado: (2022)

Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2022)

Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom
por: Tanna, Rakshit S., et al.
Publicado: (2023)

Effects of the Combination Treatment of Raloxifene and Alendronate on the Biomechanical Properties of Vertebral Bone
por: Diab, Tamim, et al.
Publicado: (2011)

Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
por: Patel, B. Divyakant, et al.
Publicado: (2012)

Effects of zearalenone and α-Zearalenol in comparison with Raloxifene on T47D cells
por: Khosrokhavar, Roya, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8sfoi2atennbjekkdh446a4n8k